Carregant...
Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
Most of the current “literature” surrounding the presence of thrombosis in COVID-19 disease and appropriate prophylaxis/treatment modalities is certainly retrospective at best, and anecdotal at worst. But in these times of rapidly changing information and perspective, an assessment of all available...
Guardat en:
| Publicat a: | J Pharm Policy Pract |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7586671/ https://ncbi.nlm.nih.gov/pubmed/33117545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-020-00274-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|